首页 > 最新文献

Journal of Ayurveda and Integrative Medicine最新文献

英文 中文
Jasminum grandiflorum oral gel as an add-on to standard of care in radiation induced grade 2 oral mucositis - an open label pilot clinical trial 将大花茉莉口服凝胶作为标准疗法的附加疗法,用于治疗辐射诱发的 2 级口腔黏膜炎--开放标签试点临床试验
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100925
A.R. Anuja , R. Anoop , Arun Mohanan , N.V. Ramesh

Background

Radiation-induced oral mucositis is one of the most critical dose-limiting toxicities associated with radiation therapy for oral cancer which can result in treatment interruption and compromise the quality of the life of cancer patients. Jati (Jasminum grandiflorum) is used in Ayurveda to treat oral conditions like stomatitis and mouth ulcers.

Objective

To test the feasibility of Jati oral gel as an add on therapy in grade 2 radiation-induced oral mucositis.

Materials and methods

A prospective, open-label, non-randomised pilot trial was conducted on 20 patients with grade 2 radiation-induced oral mucositis at a tertiary cancer hospital. The control group received sodium bicarbonate mouthwash 4–5 times daily as the standard of care, while the intervention arm also received Jati oral gel twice daily. We used the ImageJ software for objective assessment and the Visual Analogue Scale for subjective pain assessment. The study was continued for 15 days or until the mucositis progressed to grade 3 or resolved to grade 1.

Result

There was a significant reduction in the mean pain score and mean area of mucositis in the intervention group compared to the control group.

Conclusion

Jati oral gel is a suitable medicament as an add-on therapy in managing grade 2 radiation-induced oral mucositis.

背景放射治疗引起的口腔粘膜炎是口腔癌放射治疗最严重的剂量限制性毒性反应之一,可导致治疗中断并影响癌症患者的生活质量。目的测试 Jati 口腔凝胶作为 2 级放射诱导的口腔黏膜炎附加疗法的可行性。材料和方法在一家三级癌症医院对 20 名 2 级放射诱导的口腔黏膜炎患者进行了前瞻性、开放标签、非随机试验。对照组接受碳酸氢钠漱口水作为标准护理,每天 4-5 次;干预组同时接受佳迪口腔凝胶,每天两次。我们使用 ImageJ 软件进行客观评估,使用视觉模拟量表进行主观疼痛评估。结果与对照组相比,干预组的平均疼痛评分和平均粘膜炎面积显著减少。
{"title":"Jasminum grandiflorum oral gel as an add-on to standard of care in radiation induced grade 2 oral mucositis - an open label pilot clinical trial","authors":"A.R. Anuja ,&nbsp;R. Anoop ,&nbsp;Arun Mohanan ,&nbsp;N.V. Ramesh","doi":"10.1016/j.jaim.2024.100925","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100925","url":null,"abstract":"<div><h3>Background</h3><p>Radiation-induced oral mucositis is one of the most critical dose-limiting toxicities associated with radiation therapy for oral cancer which can result in treatment interruption and compromise the quality of the life of cancer patients. <em>Jati (Jasminum grandiflorum)</em> is used in Ayurveda to treat oral conditions like stomatitis and mouth ulcers.</p></div><div><h3>Objective</h3><p>To test the feasibility of <em>Jati</em> oral gel as an add on therapy in grade 2 radiation-induced oral mucositis.</p></div><div><h3>Materials and methods</h3><p>A prospective, open-label, non-randomised pilot trial was conducted on 20 patients with grade 2 radiation-induced oral mucositis at a tertiary cancer hospital. The control group received sodium bicarbonate mouthwash 4–5 times daily as the standard of care, while the intervention arm also received <em>Jati</em> oral gel twice daily. We used the ImageJ software for objective assessment and the Visual Analogue Scale for subjective pain assessment. The study was continued for 15 days or until the mucositis progressed to grade 3 or resolved to grade 1.</p></div><div><h3>Result</h3><p>There was a significant reduction in the mean pain score and mean area of mucositis in the intervention group compared to the control group.</p></div><div><h3>Conclusion</h3><p><em>Jati</em> oral gel is a suitable medicament as an add-on therapy in managing grade 2 radiation-induced oral mucositis.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100925"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000408/pdfft?md5=9b15ea528510a29e2dc9fde7b9e9170f&pid=1-s2.0-S0975947624000408-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141605357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trigonelline, a Fenugreek Bioactive protects Heart tissue against alcohol intoxication: An in-vivo study focusing on antioxidant perspective 胡芦巴生物活性物质 Trigonelline 可保护心脏组织免受酒精中毒:以抗氧化角度为重点的体内研究。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100963
Meesala Guru Sekhar , Kondeti Ramudu Shanmugam , Inavolu Srinivasa Chakrapani

Background

Trigonella foenum-graecum, commonly known as fenugreek and it is used as a spice. It has antioxidant, anti-diabetic, antilipedemic and other pharmocological properties.

Objectives

The aim of the study was to detect the cardio protective activity of Trigonelline (TG) a bioactive compound of Trigonella foenum-graecum (TF) in alcohol intoxicated rats.

Material and methods

The young wistar strain albino rats are divided in to 5 groups and treatment was given as per the experimental protocol. Antioxidant enzymes, superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), glutathione reductase (GR), glutathione (GSH), malondialdehyde (MDA) levels are estimated in cardiac tissue of all experimental groups. Cardiac markers creatine kinase-MB (CK-MB), troponin-T (TT), troponin-I (TI), myoglobin (MG) and serum markers alanine transaminase (AAT), aspartate transaminase (AST) and alkaline phosphatase (ALP) are estimated. Free radical scavenging activities like 2,2-diphenylpicrylhydrazyl (DPPH), hydrogen peroxide (H2O2) and hydroxyl radical are estimated in ethanolic extract of Trigonella foenum-graecum.

Results

SOD, CAT, GPx, GR, GSH activities are depleted and MDA, CK-MB, TT, TI, MG and AAT, AST, ALP activities are elevated in alcohol intoxicated rats. Trigonelline supplementation to alcoholic rats for 30 days elevated antioxidant enzymes, depleted MDA, cardiac markers and serum markers in alcohol intoxicated rats. Free radical scavenging assay also reported that Trigonella foenum-graecum possess free radical scavenging activity. Furthermore, our histopathological evidence also proved that TG protected the cardiac tissue from alcohol induced toxicity in all the experimental rats.

Conclusion

Our study concluded that TG may be useful to the alcoholic and myocardial infarction subjects.

背景介绍Trigonella foenum-graecum,俗称葫芦巴,是一种香料。它具有抗氧化、抗糖尿病、降血脂和其他药理特性:研究的目的是检测 Trigonelline(TG)对酒精中毒大鼠心脏的保护作用,TG 是 Trigonella foenum-graecum(TF)的一种生物活性化合物:将年轻的 Wistar 白化大鼠分为 5 组,并按照实验方案进行治疗。评估所有实验组心脏组织中的抗氧化酶、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)、过氧化氢酶(CAT)、谷胱甘肽还原酶(GR)、谷胱甘肽(GSH)、丙二醛(MDA)水平。还估测了心脏标志物肌酸激酶-MB(CK-MB)、肌钙蛋白-T(TT)、肌钙蛋白-I(TI)、肌红蛋白(MG)和血清标志物丙氨酸转氨酶(AAT)、天门冬氨酸转氨酶(AST)和碱性磷酸酶(ALP)。此外,还对三叶草乙醇提取物的自由基清除活性(如 2,2-二苯基吡啶肼(DPPH)、过氧化氢(H2O2)和羟自由基)进行了评估:结果:酒精中毒大鼠的 SOD、CAT、GPx、GR、GSH 活性降低,MDA、CK-MB、TT、TI、MG 和 AAT、AST、ALP 活性升高。给酒精中毒的大鼠补充 30 天的川芎苷可提高抗氧化酶的活性,降低 MDA、心脏指标和血清指标。自由基清除试验也表明,川芎具有清除自由基的活性。此外,我们的组织病理学证据也证明,TG 能保护所有实验鼠的心脏组织免受酒精引起的毒性:我们的研究得出结论,麦角茶可能对酒精中毒和心肌梗塞患者有用。
{"title":"Trigonelline, a Fenugreek Bioactive protects Heart tissue against alcohol intoxication: An in-vivo study focusing on antioxidant perspective","authors":"Meesala Guru Sekhar ,&nbsp;Kondeti Ramudu Shanmugam ,&nbsp;Inavolu Srinivasa Chakrapani","doi":"10.1016/j.jaim.2024.100963","DOIUrl":"10.1016/j.jaim.2024.100963","url":null,"abstract":"<div><h3>Background</h3><p><em>Trigonella foenum-graecum</em>, commonly known as fenugreek and it is used as a spice. It has antioxidant, anti-diabetic, antilipedemic and other pharmocological properties.</p></div><div><h3>Objectives</h3><p>The aim of the study was to detect the cardio protective activity of Trigonelline (TG) a bioactive compound of <em>Trigonella foenum-graecum</em> (TF) in alcohol intoxicated rats.</p></div><div><h3>Material and methods</h3><p>The young wistar strain albino rats are divided in to 5 groups and treatment was given as per the experimental protocol. Antioxidant enzymes, superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), glutathione reductase (GR), glutathione (GSH), malondialdehyde (MDA) levels are estimated in cardiac tissue of all experimental groups. Cardiac markers creatine kinase-MB (CK-MB), troponin-T (TT), troponin-I (TI), myoglobin (MG) and serum markers alanine transaminase (AAT), aspartate transaminase (AST) and alkaline phosphatase (ALP) are estimated. Free radical scavenging activities like 2,2-diphenylpicrylhydrazyl (DPPH), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and hydroxyl radical are estimated in ethanolic extract of <em>Trigonella foenum-graecum</em>.</p></div><div><h3>Results</h3><p>SOD, CAT, GPx, GR, GSH activities are depleted and MDA, CK-MB, TT, TI, MG and AAT, AST, ALP activities are elevated in alcohol intoxicated rats. Trigonelline supplementation to alcoholic rats for 30 days elevated antioxidant enzymes, depleted MDA, cardiac markers and serum markers in alcohol intoxicated rats. Free radical scavenging assay also reported that <em>Trigonella foenum-graecum</em> possess free radical scavenging activity. Furthermore, our histopathological evidence also proved that TG protected the cardiac tissue from alcohol induced toxicity in all the experimental rats.</p></div><div><h3>Conclusion</h3><p>Our study concluded that TG may be useful to the alcoholic and myocardial infarction subjects.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100963"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000780/pdfft?md5=d525e4e9484078802ad2b0d1241aa656&pid=1-s2.0-S0975947624000780-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141906642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic potential of Ficus benghalensis in thromboembolic disorders 榕树对血栓栓塞性疾病的治疗潜力。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100929
Anil Kumar Sahu , Drishya Dinesh , Vipin Kumar Verma, Vaishali Prajapati, Jagriti Bhatia, Dharamvir Singh Arya

Objective

Ficus benghalensis L. (FB) is a popular plant described in the Indian system of medicine. Traditionally, it is indicated in the treatment of diseases like diabetes mellitus, dysentery, leucorrhoea, menorrhagia, skin disease, rheumatism, inflammatory diseases, blood disorders. This paper accentuates the anti-thrombotic action of FB based on the properties like anti-coagulant, platelet-antiaggregatory, anti-atherogenic hypotensive, hypolipidemic, anti-oxidant, anti-inflammatory and immunomodulatory.

Methods

All the available data pertaining to FB has been searched in the scientific databases, including PubMed, Google Scholar, ScienceDirect and Scopus.

Results

FB is a rich lode of organic compounds such as phenols, flavonoids, alkaloids, tannins, terpenoids and steroids. The various studies show that these phytochemical constituents exhibit wide range of anti-thrombotic actions such as anticoagulant, platelet anti-aggregatory, anti-atherogenic, hypolipidemic, hypotensive, anti-inflammatory, and antioxidant.

Conclusion

Various studies (in vitro and in vivo) confirm the potential anti-thrombotic benefit of FB due to the presence of chemical structures that have proven to be effective in thromboembolic conditions. These evidences may benefit in new drug development to treat varied thromboembolic conditions which will not only be cost effective but may allay the fear of side effects.

目的:Ficus benghalensis L.(FB)是印度医学体系中描述的一种常用植物。传统上,它适用于治疗糖尿病、痢疾、白带、月经过多、皮肤病、风湿病、炎症、血液疾病等疾病。本文根据枸杞多糖的抗凝血、抗血小板聚集、抗动脉粥样硬化、降血脂、抗氧化、抗炎和免疫调节等特性,重点介绍了枸杞多糖的抗血栓作用:方法:在PubMed、Google Scholar、ScienceDirect和Scopus等科学数据库中搜索了所有与枸杞多糖有关的可用数据:结果:枸杞含有丰富的有机化合物,如酚类、黄酮类、生物碱、单宁、萜类和类固醇。各种研究表明,这些植物化学成分具有广泛的抗血栓作用,如抗凝血、抗血小板聚集、抗动脉粥样硬化、降血脂、降血压、抗炎和抗氧化:各种研究(体外和体内)证实,由于枸杞多糖的化学结构已被证明对血栓栓塞性疾病有效,因此枸杞多糖具有潜在的抗血栓作用。这些证据可能有助于开发治疗各种血栓栓塞病症的新药,这不仅具有成本效益,还能减轻对副作用的担忧。
{"title":"Therapeutic potential of Ficus benghalensis in thromboembolic disorders","authors":"Anil Kumar Sahu ,&nbsp;Drishya Dinesh ,&nbsp;Vipin Kumar Verma,&nbsp;Vaishali Prajapati,&nbsp;Jagriti Bhatia,&nbsp;Dharamvir Singh Arya","doi":"10.1016/j.jaim.2024.100929","DOIUrl":"10.1016/j.jaim.2024.100929","url":null,"abstract":"<div><h3>Objective</h3><p><em>Ficus benghalensis</em> L. (<em>FB</em>) is a popular plant described in the Indian system of medicine. Traditionally, it is indicated in the treatment of diseases like diabetes mellitus, dysentery, leucorrhoea, menorrhagia, skin disease, rheumatism, inflammatory diseases, blood disorders. This paper accentuates the anti-thrombotic action of <em>FB</em> based on the properties like anti-coagulant, platelet-antiaggregatory, anti-atherogenic hypotensive, hypolipidemic, anti-oxidant, anti-inflammatory and immunomodulatory.</p></div><div><h3>Methods</h3><p>All the available data pertaining to <em>FB</em> has been searched in the scientific databases, including PubMed, Google Scholar, ScienceDirect and Scopus.</p></div><div><h3>Results</h3><p><em>FB</em> is a rich lode of organic compounds such as phenols, flavonoids, alkaloids, tannins, terpenoids and steroids. The various studies show that these phytochemical constituents exhibit wide range of anti-thrombotic actions such as anticoagulant, platelet <em>anti</em>-aggregatory, anti-atherogenic, hypolipidemic, hypotensive, anti-inflammatory, and antioxidant.</p></div><div><h3>Conclusion</h3><p>Various studies (<em>in vitro</em> and <em>in vivo</em>) confirm the potential anti-thrombotic benefit of <em>FB</em> due to the presence of chemical structures that have proven to be effective in thromboembolic conditions. These evidences may benefit in new drug development to treat varied thromboembolic conditions which will not only be cost effective but may allay the fear of side effects.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100929"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000445/pdfft?md5=25d7ebc995ffa03d8fa03ebfcf034457&pid=1-s2.0-S0975947624000445-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141897522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of tryushnadya churna in metabolic syndrome with obesity – A randomized double blind controlled clinical trial tryushnadya churna 对代谢综合征合并肥胖症的疗效--随机双盲对照临床试验。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100973
Soujanya Chandake , Basavaraj R. Tubaki , Varsha Gonugade , Oshin Sharma

Background

Metabolic syndrome (MetS) with obesity has significant mortality and morbidity. Integrative Ayurveda management is explored for it's possible effect.

Aim

To evaluate the effect of Tryushnadi churna in the management of Metabolic syndrome with obesity.

Methods

Study is a Randomized, Controlled, double blind, parallel group comparative clinical trial. 48 participants meeting the National Cholesterol Education Programme Adult Treatment panel 3 diagnostic criteria were recruited in the study. They were divided in two 2 groups. Placebo group were administered with Placebo 1 gm twice a day, Ayurveda diet and yoga. Tryushnadi Group were intervened with Tryushnadi churna 1 gm twice a day, Ayurveda diet and yoga. Interventions were for 90 days. Assessments criteria included Weight, BMI,Waist circumference (WC), Waist hip ratio, Skin fold thickness (SFT), Body fat, blood pressure, WHO-QOL BREF scale, Clinical Global Impression Scale (CGI)- Severity, Global improvement and Efficacy index, Fasting blood sugar (FBS) were assessed on every 30th day. Other blood parameters like Glycated haemoglobin (HbA1c), Triglycerides, High density lipoproteins (HDL), Low density lipoproteins (LDL), Total cholesterol (TC) were evaluated at pre and post study.

Results

Between groups comparison showed, Tryushnadi group had significant improvements in BMI, Weight, WHOQOL-Bref and had large effect size. Both the groups showed improvement in WC, body fat, SFT, CGI severity, CGI efficacy index and improvement in quality of life in within group assessment.

Conclusion

Study showed that Tryushnadi churna was effective in management of MetS with Obesity. Integrated management of Ayurveda medicine, Ayurveda diet and yoga had beneficial effect.

背景:代谢综合征(MetS)合并肥胖症的死亡率和发病率都很高。目的:评估 Tryushnadi churna 在治疗代谢综合征合并肥胖症方面的效果:研究是一项随机、对照、双盲、平行组比较临床试验。研究招募了 48 名符合国家胆固醇教育计划成人治疗小组 3 诊断标准的参与者。他们被分为两组。安慰剂组服用安慰剂,每次 1 克,每天两次;阿育吠陀饮食和瑜伽组服用阿育吠陀饮食和瑜伽。Tryushnadi组使用Tryushnadi churna,每次1克,每天2次,同时配合阿育吠陀饮食和瑜伽。干预为期 90 天。评估标准包括体重、体重指数(BMI)、腰围(WC)、腰臀比、皮肤褶皱厚度(SFT)、体脂、血压、WHO-QOL BREF 量表、临床整体印象量表(CGI)--严重程度、整体改善程度和疗效指数。研究前后还评估了其他血液参数,如糖化血红蛋白(HbA1c)、甘油三酯、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、总胆固醇(TC):组间比较显示,Tryushnadi 组在体重指数、体重、WHOQOL-Bref 方面有明显改善,且效果显著。在组内评估中,两组在体重指数、体脂、SFT、CGI 严重程度、CGI 有效指数和生活质量方面均有改善:研究表明,Tryushnadi churna 能有效治疗代谢性肥胖症。阿育吠陀医学、阿育吠陀饮食和瑜伽的综合管理效果显著。
{"title":"Efficacy of tryushnadya churna in metabolic syndrome with obesity – A randomized double blind controlled clinical trial","authors":"Soujanya Chandake ,&nbsp;Basavaraj R. Tubaki ,&nbsp;Varsha Gonugade ,&nbsp;Oshin Sharma","doi":"10.1016/j.jaim.2024.100973","DOIUrl":"10.1016/j.jaim.2024.100973","url":null,"abstract":"<div><h3>Background</h3><p>Metabolic syndrome (MetS) with obesity has significant mortality and morbidity. Integrative Ayurveda management is explored for it's possible effect.</p></div><div><h3>Aim</h3><p>To evaluate the effect of Tryushnadi churna in the management of Metabolic syndrome with obesity.</p></div><div><h3>Methods</h3><p>Study is a Randomized, Controlled, double blind, parallel group comparative clinical trial. 48 participants meeting the National Cholesterol Education Programme Adult Treatment panel 3 diagnostic criteria were recruited in the study. They were divided in two 2 groups. Placebo group were administered with Placebo 1 gm twice a day, Ayurveda diet and yoga. Tryushnadi Group were intervened with Tryushnadi churna 1 gm twice a day, Ayurveda diet and yoga. Interventions were for 90 days. Assessments criteria included Weight, BMI,Waist circumference (WC), Waist hip ratio, Skin fold thickness (SFT), Body fat, blood pressure, WHO-QOL BREF scale, Clinical Global Impression Scale (CGI)- Severity, Global improvement and Efficacy index, Fasting blood sugar (FBS) were assessed on every 30th day. Other blood parameters like Glycated haemoglobin (HbA1c), Triglycerides, High density lipoproteins (HDL), Low density lipoproteins (LDL), Total cholesterol (TC) were evaluated at pre and post study.</p></div><div><h3>Results</h3><p>Between groups comparison showed, Tryushnadi group had significant improvements in BMI, Weight, WHOQOL-Bref and had large effect size. Both the groups showed improvement in WC, body fat, SFT, CGI severity, CGI efficacy index and improvement in quality of life in within group assessment.</p></div><div><h3>Conclusion</h3><p>Study showed that Tryushnadi churna was effective in management of MetS with Obesity. Integrated management of Ayurveda medicine, Ayurveda diet and yoga had beneficial effect.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100973"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000883/pdfft?md5=5491ca789ab999215449464a40102c93&pid=1-s2.0-S0975947624000883-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141916777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurveda in the integrative management of bovine secondary recumbency-a case report 阿育吠陀在牛继发性腰痛综合治疗中的应用--病例报告。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100962
Reshma R , Unnikrishnan K

Downer cow syndrome, or secondary recumbency, is a condition primarily affecting dairy cows, where the animal is unable to rise and stand, due to unknown cause. It is usually associated with poor prognosis. Terminal downers are euthanized in most countries. A four-year old Kasarkode dwarf-cow, post-calving was brought up laterally recumbent with heavy nasal discharge, labored breathing, loss of appetite and signs of dehydration on 6th day of its recumbency. Before this, the patient was diagnosed with milk fever and standard treatment with calcium borogluconate was administered intravenously. The animal was left to succumb under unprotected conditions, due to various constraints on euthanasia. After adopting the cow, Nasya was started immediately to avoid death due to sepsis and shock. The animal was drenched with Ayurvedic fluids containing deepana-pacana herbs. Sternal recumbency, warm and moistened muzzle was observed on the fourth day of commencing ayurvedic treatment. Respiratory distress was minimal. Drastic prognostic shift from “no hope” to “good” was possible within 6 days thanks to Nasya, and the animal was stable. Thereafter, integrative care comprising of antibiotics, rehydrating IV fluids, and supplementations, along with ayurvedic medicines was initiated. Ruminal-fluid obtained from slaughterhouse was used for ruminal-flora replacement. Rumination on 14th day, cow on its feet by 19th day and complete healing of decubital ulcers by approximately 40 days was recorded. A downed cow which did not respond to standard veterinary care was managed with Ayurveda-integrated veterinary care. Ayurveda herbs like bamboo leaves (Bambusa vulgaris), green chiretta (Andrographis paniculata) that cattle prefer eating during certain illness, turn out to be useful for Ayurvedic management. Hence, Ayurveda veterinary medicine might be, a good choice for integrative management of terminal downers, preventing early death in downed dairy cows.

唐氏奶牛综合症或继发性卧地不起是一种主要影响奶牛的病症,病因不明,动物无法起立和站立。这种病通常预后不良。在大多数国家,临终瘫痪的奶牛都会被安乐死。一头四岁大的卡萨科德(Kasarkode)矮种奶牛在产犊后第 6 天出现侧卧,流大量鼻液,呼吸困难,食欲不振,有脱水症状。在此之前,患者被诊断为牛奶热,并接受了硼葡萄糖酸钙的标准静脉注射治疗。由于安乐术的种种限制,这头奶牛只能在没有保护的情况下死去。在收养这头奶牛后,为避免其因败血症和休克而死亡,立即开始了 Nasya 治疗。用含有deepana-pacana草药的阿育吠陀药液浸泡牛体。在开始阿育吠陀疗法的第四天,观察到该牛胸骨后仰,口部温暖湿润。呼吸困难的程度很轻。在 Nasya 的帮助下,动物的预后在 6 天内从 "无望 "转为 "良好",病情稳定。此后,开始了综合治疗,包括抗生素、静脉补液、补充剂和阿育吠陀药物。从屠宰场获得的瘤胃液被用于补充瘤胃菌群。记录显示,奶牛在第 14 天开始反刍,第 19 天开始站立,约 40 天后褥疮完全愈合。对标准兽医治疗无效的倒地奶牛采用了阿育吠陀综合兽医治疗。阿育吠陀草药,如竹叶(Bambusa vulgaris)、绿穿心莲(Andrographis paniculata)等牛在某些疾病期间喜欢吃的草药,在阿育吠陀治疗中都很有用。因此,阿育吠陀兽医疗法可能是综合治疗晚疫病、防止晚疫奶牛过早死亡的不错选择。
{"title":"Ayurveda in the integrative management of bovine secondary recumbency-a case report","authors":"Reshma R ,&nbsp;Unnikrishnan K","doi":"10.1016/j.jaim.2024.100962","DOIUrl":"10.1016/j.jaim.2024.100962","url":null,"abstract":"<div><p>Downer cow syndrome, or secondary recumbency, is a condition primarily affecting dairy cows, where the animal is unable to rise and stand, due to unknown cause. It is usually associated with poor prognosis. Terminal downers are euthanized in most countries. A four-year old <em>Kasarkode</em> dwarf-cow, post-calving was brought up laterally recumbent with heavy nasal discharge, labored breathing, loss of appetite and signs of dehydration on 6th day of its recumbency. Before this, the patient was diagnosed with milk fever and standard treatment with calcium borogluconate was administered intravenously. The animal was left to succumb under unprotected conditions, due to various constraints on euthanasia. After adopting the cow, <em>Nasya</em> was started immediately to avoid death due to sepsis and shock. The animal was drenched with Ayurvedic fluids containing <em>deepana-pacana</em> herbs. Sternal recumbency, warm and moistened muzzle was observed on the fourth day of commencing ayurvedic treatment. Respiratory distress was minimal. Drastic prognostic shift from “no hope” to “good” was possible within 6 days thanks to Nasya, and the animal was stable. Thereafter, integrative care comprising of antibiotics, rehydrating IV fluids, and supplementations, along with ayurvedic medicines was initiated. Ruminal-fluid obtained from slaughterhouse was used for ruminal-flora replacement. Rumination on 14th day, cow on its feet by 19th day and complete healing of decubital ulcers by approximately 40 days was recorded. A downed cow which did not respond to standard veterinary care was managed with Ayurveda-integrated veterinary care. Ayurveda herbs like bamboo leaves (<em>Bambusa vulgaris</em>), green chiretta (<em>Andrographis paniculata)</em> that cattle prefer eating during certain illness, turn out to be useful for Ayurvedic management. Hence, Ayurveda veterinary medicine might be, a good choice for integrative management of terminal downers, preventing early death in downed dairy cows.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100962"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000779/pdfft?md5=01884ae40b7826bdabe28f4760c2499c&pid=1-s2.0-S0975947624000779-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of yoga and add on Ayurvedic Kati Basti therapy for patients with chronic low back pain: A randomized controlled trial 瑜伽和阿育吠陀 Kati Basti疗法对慢性腰背痛患者的影响:随机对照试验
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.101030
Maheshwor Bhatta , Suchitra S. Patil , Sunil Singh Yadav , Sangeeth Somanadhapai , Rita Thapa

Background

Chronic low back pain (CLBP) signficantly affects quality of life and productivity, leading to limitations in mobility, activity, and potential work absenteesim. Yoga and Ayurveda have shown promising evidence in reducing pain, improve function, and enhancing well-being for individuals with CLBP, as demonstrated by numerous studies.

Objectives

The aim of this study is to assess the effect of a 1-week residential integrative approach to yoga therapy. (IAYT) alone versus when combined with Ayurveda therapy (Kati Basti) in patients with CLBP.

Methods

Forty patients were recruited from E-section of a holistic health center in South India for randomization and split into a Yoga and Ayurveda (n=20) and a Yoga-only (n=20) group. Yoga and Ayurveda group received a 1-week residential program combining Yoga and Ayurveda (therapy including Kati Basti with Ksheerbala Taila), while the Yoga-only group received only yoga therapy. Assessments at baseline, 1-week, and three months were measure pain intensity, disability, and depression.

Results

Both Yoga and Ayurveda group, and Yoga-only group showed significant reductions in pain and improvements in disability and depression at 1-week and three months. Quality of life also improved, specifically in physical, social, environmental, and psychological health. No significant differences were found between the groups in terms of pain, disability, and depression.

Conclusion

Both interventions demonstrated comparable results in pain reduction and disability improvement, as well as alleviating depression symptoms. Only Yoga and Ayurveda group exhibited improvement in physical health. Further research should explore long-term effects and compare different yoga interventions.

背景 慢性腰背痛(CLBP)严重影响生活质量和工作效率,导致行动不便、活动受限和潜在的缺勤。瑜伽和阿育吠陀在减轻慢性腰背痛患者的疼痛、改善其功能和提高其幸福感方面显示出良好的效果,这一点已被大量研究证实。(方法从南印度一家整体健康中心的 E 区招募 40 名患者进行随机分组,分为瑜伽和阿育吠陀组(20 人)和纯瑜伽组(20 人)。瑜伽和阿育吠陀组接受为期一周的住宿计划,该计划结合了瑜伽和阿育吠陀(疗法包括 Kati Basti 和 Ksheerbala Taila),而纯瑜伽组仅接受瑜伽疗法。结果瑜伽和阿育吠陀组以及纯瑜伽组在一周和三个月后疼痛明显减轻,残疾和抑郁情况也有所改善。生活质量也有所提高,特别是在身体、社交、环境和心理健康方面。结论两种干预方法在减轻疼痛、改善残疾状况以及缓解抑郁症状方面的效果相当。只有瑜伽和阿育吠陀组在身体健康方面有所改善。进一步的研究应探讨长期效果,并对不同的瑜伽干预措施进行比较。
{"title":"Effects of yoga and add on Ayurvedic Kati Basti therapy for patients with chronic low back pain: A randomized controlled trial","authors":"Maheshwor Bhatta ,&nbsp;Suchitra S. Patil ,&nbsp;Sunil Singh Yadav ,&nbsp;Sangeeth Somanadhapai ,&nbsp;Rita Thapa","doi":"10.1016/j.jaim.2024.101030","DOIUrl":"10.1016/j.jaim.2024.101030","url":null,"abstract":"<div><h3>Background</h3><p>Chronic low back pain (CLBP) signficantly affects quality of life and productivity, leading to limitations in mobility, activity, and potential work absenteesim. Yoga and Ayurveda have shown promising evidence in reducing pain, improve function, and enhancing well-being for individuals with CLBP, as demonstrated by numerous studies.</p></div><div><h3>Objectives</h3><p>The aim of this study is to assess the effect of a 1-week residential integrative approach to yoga therapy. (IAYT) alone versus when combined with Ayurveda therapy (<em>Kati Basti</em>) in patients with CLBP.</p></div><div><h3>Methods</h3><p>Forty patients were recruited from E-section of a holistic health center in South India for randomization and split into a Yoga and Ayurveda (<em>n</em>=20) and a Yoga-only (<em>n</em>=20) group. Yoga and Ayurveda group received a 1-week residential program combining Yoga and Ayurveda (therapy including <em>Kati Basti with Ksheerbala Taila</em>), while the Yoga-only group received only yoga therapy. Assessments at baseline, 1-week, and three months were measure pain intensity, disability, and depression.</p></div><div><h3>Results</h3><p>Both Yoga and Ayurveda group, and Yoga-only group showed significant reductions in pain and improvements in disability and depression at 1-week and three months. Quality of life also improved, specifically in physical, social, environmental, and psychological health. No significant differences were found between the groups in terms of pain, disability, and depression.</p></div><div><h3>Conclusion</h3><p>Both interventions demonstrated comparable results in pain reduction and disability improvement, as well as alleviating depression symptoms. Only Yoga and Ayurveda group exhibited improvement in physical health. Further research should explore long-term effects and compare different yoga interventions.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 101030"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624001451/pdfft?md5=3be7761aa43b0c029bcdca9ceb129a82&pid=1-s2.0-S0975947624001451-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142049834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indian Ayurvedic medicine: Overview and application to brain cancer 印度阿育吠陀医学:概述及在脑癌中的应用
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.101013
Herbert B. Newton

Ayurveda is the traditional medicine system of India, and has been in practice for millennia. It is a traditional approach that uses 1000's of different plant preparations in various combinations for treatment of human ailments, including cancer. Ethnopharmacological and phytochemical analyses are now elucidating the bioactive constituents of the different plant species and herbal formulations, including ashwagandha, curcumin, guduchi, triphala, and others.

To provide an overview of: 1) the ethnopharmacology of Ayurveda and several of its most important plant species and formulations, including pharmacological and molecular mechanisms of its anti-cancer effects; 2) review the literature applying Ayurvedic herbs and formulations to brain tumors.

A detailed PubMed search was performed that included publications involving Ayurveda, cancer, ethnopharmacology, phytochemical analysis, molecular analysis, and brain tumors.

In recent decades, significant research has begun to elucidate the bioactive compounds of ashwagandha, tumeric, guduchi, and triphala, such as withaferin A, withanolides, curcumin, palmatine, and many others. These compounds and extracts are now being applied to brain tumor cells in vitro and in animal models, with positive signs of anti-cancer activity including reduced cell growth, increased apoptosis, cell cycle arrest, increased differentiation, and inhibition of important internal signal transduction pathways.

Several Ayurvedic herbs (ashwagandha, curcumin) have bioactive compounds with significant anti-cancer activity, and are effective in early pre-clinical testing against brain tumor cells in vitro and in animal models. Further pre-clinical testing is warranted, along with advancement into phase I and phase II clinical trials of patients with glioblastoma and other brain tumors.

阿育吠陀是印度的传统医学体系,已有千年历史。阿育吠陀是印度的传统医学体系,已有数千年的历史。它采用传统方法,将 1000 多种不同的植物制剂进行各种组合,用于治疗包括癌症在内的人类疾病。目前,民族药理学和植物化学分析正在阐明不同植物物种和草药配方的生物活性成分,包括灰树叶、姜黄素、古杜奇、三叶草等:1) 阿育吠陀的民族药理学及其几种最重要的植物品种和配方,包括其抗癌作用的药理学和分子机制;2) 综述将阿育吠陀草药和配方应用于脑肿瘤的文献。我们在 PubMed 上进行了详细搜索,包括涉及阿育吠陀、癌症、民族药理学、植物化学分析、分子分析和脑肿瘤的出版物。近几十年来,大量研究已开始阐明灰树叶、吐根、古杜奇和三叶草的生物活性化合物,如含铁血黄素 A、黄烷醇内酯、姜黄素、巴马汀等。目前,这些化合物和提取物正被用于体外和动物模型中的脑肿瘤细胞,并出现了抗癌活性的积极迹象,包括减少细胞生长、增加细胞凋亡、细胞周期停滞、增加分化和抑制重要的内部信号转导途径。一些阿育吠陀草药(灰树花、姜黄素)中的生物活性化合物具有显著的抗癌活性,在早期临床前试验中对体外和动物模型中的脑肿瘤细胞有效。有必要进一步进行临床前试验,并推进对胶质母细胞瘤和其他脑肿瘤患者的 I 期和 II 期临床试验。
{"title":"Indian Ayurvedic medicine: Overview and application to brain cancer","authors":"Herbert B. Newton","doi":"10.1016/j.jaim.2024.101013","DOIUrl":"10.1016/j.jaim.2024.101013","url":null,"abstract":"<div><p>Ayurveda is the traditional medicine system of India, and has been in practice for millennia. It is a traditional approach that uses 1000's of different plant preparations in various combinations for treatment of human ailments, including cancer. Ethnopharmacological and phytochemical analyses are now elucidating the bioactive constituents of the different plant species and herbal formulations, including ashwagandha, curcumin, guduchi, triphala, and others.</p><p>To provide an overview of: 1) the ethnopharmacology of Ayurveda and several of its most important plant species and formulations, including pharmacological and molecular mechanisms of its anti-cancer effects; 2) review the literature applying Ayurvedic herbs and formulations to brain tumors.</p><p>A detailed PubMed search was performed that included publications involving Ayurveda, cancer, ethnopharmacology, phytochemical analysis, molecular analysis, and brain tumors.</p><p>In recent decades, significant research has begun to elucidate the bioactive compounds of ashwagandha, tumeric, guduchi, and triphala, such as withaferin A, withanolides, curcumin, palmatine, and many others. These compounds and extracts are now being applied to brain tumor cells <em>in vitro</em> and in animal models, with positive signs of anti-cancer activity including reduced cell growth, increased apoptosis, cell cycle arrest, increased differentiation, and inhibition of important internal signal transduction pathways.</p><p>Several Ayurvedic herbs (ashwagandha, curcumin) have bioactive compounds with significant anti-cancer activity, and are effective in early pre-clinical testing against brain tumor cells <em>in vitro</em> and in animal models. Further pre-clinical testing is warranted, along with advancement into phase I and phase II clinical trials of patients with glioblastoma and other brain tumors.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 101013"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624001281/pdfft?md5=03d9a8aedfb3f5972e5386f43fd69bbf&pid=1-s2.0-S0975947624001281-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142049835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Criteria to select a research “topic” for postgraduate and doctoral studies in ayurveda 选择阿育吠陀研究生和博士生研究 "课题 "的标准
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100978
Sathya N. Dornala , Snehalatha SN. Dornala

A research topic is a subject or problem that an investigator is interested in research. The starting point of any research project that is successful is a well-defined subject of research. The selection of topics is an ongoing approach in which investigators analyse, describe, classify, and refine their ideas. For the ease of selection of topics particularly in the field of Ayurveda, Authors have created an acronym ‘TOPIC’ as a guiding tool for the selection of the area of research. The components of the TOPIC criterion are Textual & Time-bound; Objectivity & Outcome measures; Planning & Pragmatic; Innovative & Interesting and Contemporarily relevant & Consent, highlight useful points for the easy selection of the topic for the research by the novice.

研究课题是研究人员有兴趣研究的主题或问题。任何成功的研究项目的起点都是一个明确的研究课题。选题是一项持续性的工作,研究人员需要对自己的想法进行分析、描述、分类和完善。为了便于选题,尤其是阿育吠陀领域的选题,作者创造了一个缩写词 "TOPIC",作为选择研究领域的指导工具。TOPIC "标准的组成部分包括:文字性& 有时限性; 客观性& 成果衡量标准; 计划性& 实用性; 创新性& 有趣性和当代相关性& 同意,强调了新手轻松选择研究课题的有用要点。
{"title":"Criteria to select a research “topic” for postgraduate and doctoral studies in ayurveda","authors":"Sathya N. Dornala ,&nbsp;Snehalatha SN. Dornala","doi":"10.1016/j.jaim.2024.100978","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100978","url":null,"abstract":"<div><p>A research topic is a subject or problem that an investigator is interested in research. The starting point of any research project that is successful is a well-defined subject of research. The selection of topics is an ongoing approach in which investigators analyse, describe, classify, and refine their ideas. For the ease of selection of topics particularly in the field of Ayurveda, Authors have created an acronym ‘TOPIC’ as a guiding tool for the selection of the area of research. The components of the TOPIC criterion are <strong>T</strong>extual &amp; Time-bound; <strong>O</strong>bjectivity &amp; Outcome measures; Planning &amp; Pragmatic; <strong>I</strong>nnovative &amp; Interesting and <strong>C</strong>ontemporarily relevant &amp; Consent, highlight useful points for the easy selection of the topic for the research by the novice.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100978"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000937/pdfft?md5=2159fcecb239f70886dafd05387a3295&pid=1-s2.0-S0975947624000937-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141541104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shilajit mitigates chemotherapeutic drug-induced testicular toxicity: Study on testicular germ cell dynamics, steroidogenesis modulation, and Nrf-2/Keap-1 signaling 夏拉吉减轻化疗药物引起的睾丸毒性:睾丸生殖细胞动力学、类固醇生成调节和Nrf-2/Keap-1信号传导研究
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100930
Arti Rajpoot, Kiran Yadav, Anupam Yadav, Raghav Kumar Mishra

Background

Medications, including chemotherapeutic drugs, contribute to male infertility as external factors by inducing oxidative stress in testicular cells. Shilajit is a naturally occurring bioactive antioxidant used in Ayurvedic medicine to treat a variety of ailments.

Objective

This study examines the potential of Shilajit to counteract the negative effects of the chemotherapeutic drug cyclophosphamide (CPA) on testicular germ cell dynamics.

Material and methods

Male Parkes mice received single intraperitoneal CPA injection (200 mg/kg BW) on day one, followed by daily supplementation of Shilajit (100 and 200 mg/kg BW) for one spermatogenic cycle.

Results

CPA adversely affected testicular germ cell dynamics by inhibiting the conversion of spermatogonia-to-spermatids, altering testicular histoarchitecture, impairing Sertoli cell function and testicular steroidogenesis, and disturbing the testicular oxido-apoptotic balance. Shilajit supplementation restores testicular germ cell dynamics in CPA-exposed mice, as evidenced by improved histoarchitecture of the testis. Shilajit improves testicular daily production and sperm quality by promoting the conversion of spermatogonia (2C) into spermatids (1C), stimulating germ cell proliferation (PCNA), improving Sertoli cell function (N-Cadherin and β-Catenin), and maintaining the Bax/Bcl2 ratio. Additionally, Shilajit enhances testosterone biosynthesis by activating enzymes like 3β-HSD, and 17β-HSD. Shilajit also reduces testicular oxidative stress by increasing antioxidant enzyme activity (SOD) and decreasing lipid peroxidation (LPO). These effects are mediated by upregulation of the antioxidant protein Nrf-2 and downregulation of Keap-1.

Conclusion

The findings underscore the potent androgenic and antioxidant characteristics of Shilajit, as well as its ability to enhance fertility in cases of testicular damage caused by chemotherapeutic drugs.

背景:包括化疗药物在内的药物通过诱导睾丸细胞的氧化应激,作为外部因素导致男性不育。Shilajit是一种天然生物活性抗氧化剂,在阿育吠陀医学中被用于治疗多种疾病:本研究探讨了夏拉杰特抵消化疗药物环磷酰胺(CPA)对睾丸生殖细胞动力学负面影响的潜力:雄性Parkes小鼠在第一天腹腔注射单次CPA(200毫克/千克体重),然后每天补充Shilajit(100和200毫克/千克体重),持续一个生精周期:结果:CPA通过抑制精原细胞向精母细胞的转化、改变睾丸组织结构、损害Sertoli细胞功能和睾丸类固醇生成以及扰乱睾丸氧化-凋亡平衡,对睾丸生精细胞动力学产生了不利影响。睾丸组织结构的改善证明,补充夏拉杰特能恢复暴露于 CPA 的小鼠睾丸生殖细胞的活力。通过促进精原细胞(2C)转化为精子细胞(1C)、刺激生殖细胞增殖(PCNA)、改善Sertoli细胞功能(N-Cadherin和β-Catenin)以及维持Bax/Bcl2比率,夏拉吉提提高了睾丸的日产量和精子质量。此外,夏拉吉通过激活 3β-HSD 和 17β-HSD 等酶来增强睾酮的生物合成。夏拉吉提还能通过提高抗氧化酶活性(SOD)和降低脂质过氧化反应(LPO)来减少睾丸氧化应激。这些作用是通过上调抗氧化蛋白 Nrf-2 和下调 Keap-1 来实现的:结论:研究结果强调了夏拉杰特(Shilajit)的强效雄激素和抗氧化特性,以及在化疗药物导致睾丸损伤的情况下提高生育能力的能力。
{"title":"Shilajit mitigates chemotherapeutic drug-induced testicular toxicity: Study on testicular germ cell dynamics, steroidogenesis modulation, and Nrf-2/Keap-1 signaling","authors":"Arti Rajpoot,&nbsp;Kiran Yadav,&nbsp;Anupam Yadav,&nbsp;Raghav Kumar Mishra","doi":"10.1016/j.jaim.2024.100930","DOIUrl":"10.1016/j.jaim.2024.100930","url":null,"abstract":"<div><h3>Background</h3><p>Medications, including chemotherapeutic drugs, contribute to male infertility as external factors by inducing oxidative stress in testicular cells. Shilajit is a naturally occurring bioactive antioxidant used in Ayurvedic medicine to treat a variety of ailments.</p></div><div><h3>Objective</h3><p>This study examines the potential of Shilajit to counteract the negative effects of the chemotherapeutic drug cyclophosphamide (CPA) on testicular germ cell dynamics.</p></div><div><h3>Material and methods</h3><p>Male Parkes mice received single intraperitoneal CPA injection (200 mg/kg BW) on day one, followed by daily supplementation of Shilajit (100 and 200 mg/kg BW) for one spermatogenic cycle.</p></div><div><h3>Results</h3><p>CPA adversely affected testicular germ cell dynamics by inhibiting the conversion of spermatogonia-to-spermatids, altering testicular histoarchitecture, impairing Sertoli cell function and testicular steroidogenesis, and disturbing the testicular oxido-apoptotic balance. Shilajit supplementation restores testicular germ cell dynamics in CPA-exposed mice, as evidenced by improved histoarchitecture of the testis. Shilajit improves testicular daily production and sperm quality by promoting the conversion of spermatogonia (2C) into spermatids (1C), stimulating germ cell proliferation (PCNA), improving Sertoli cell function (<em>N</em>-Cadherin and β-Catenin), and maintaining the Bax/Bcl2 ratio. Additionally, Shilajit enhances testosterone biosynthesis by activating enzymes like 3β-HSD, and 17β-HSD. Shilajit also reduces testicular oxidative stress by increasing antioxidant enzyme activity (SOD) and decreasing lipid peroxidation (LPO). These effects are mediated by upregulation of the antioxidant protein Nrf-2 and downregulation of Keap-1.</p></div><div><h3>Conclusion</h3><p>The findings underscore the potent androgenic and antioxidant characteristics of Shilajit, as well as its ability to enhance fertility in cases of testicular damage caused by chemotherapeutic drugs.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100930"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000457/pdfft?md5=af3608f199f4c559dca7e0e6ea4faece&pid=1-s2.0-S0975947624000457-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Ayurvedic practices on quality of life of health professionals in Brazil: trends from a quasi experimental study 阿育吠陀疗法对巴西保健专业人员生活质量的影响:一项准实验研究的趋势。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100932
Barbara Esteves das Neves, Nina Claudia Barboza da Silva

Integral health encompasses the way individuals live, considering their quality of life. An inadequate lifestyle can harm human health, increasing the risk of developing chronic non-communicable diseases, which represent 71% of the causes of death worldwide and 54.7% in Brazil. The COVID-19 pandemic has led to impacts on quality of life, resulting from lifestyle changes, especially among health professionals. This constitutes an important factor in the health-disease relationship and the core of the healthcare approach embraced by Ayurveda. The present study evaluated the role of daily Ayurvedic practices in improving the quality of life of health professionals working in the Family Health Strategy of SUS in Paty do Alferes/RJ, Brazil. Ayurveda practices based on Trayopastamba were introduced to 30 health professionals through lectures and guided activities from July to October 2021, spanning three months. Quality of life was assessed using the WHOQOL-BREF questionnaire before and after the intervention. An improvement in perceived quality of life was observed in the physical, psychological, and environmental domains (p > 0.05), while the social domain did not show statistically significant results. The physical domain demonstrated the most substantial score increase (10.95). Conversely, the social domain displayed the smallest rise in scores (5.83). In conclusion, the daily Ayurvedic practices demonstrated the potential to enhance the quality of life in this group, contributing to health promotion in a practical and economically accessible manner.

整体健康包括个人的生活方式,考虑到他们的生活质量。不适当的生活方式会损害人类健康,增加罹患慢性非传染性疾病的风险,这些疾病占全球死亡原因的 71%,在巴西占 54.7%。COVID-19 大流行导致生活方式的改变,对生活质量产生了影响,尤其是在医疗专业人员中。这是健康与疾病关系中的一个重要因素,也是阿育吠陀所采用的保健方法的核心。本研究评估了日常阿育吠陀实践在改善巴西 Paty do Alferes/RJ 卫生系统家庭保健战略中卫生专业人员生活质量方面的作用。2021 年 7 月至 10 月,在为期三个月的时间里,通过讲座和指导活动向 30 名卫生专业人员介绍了以 Trayopastamba 为基础的阿育吠陀实践。在干预前后,使用世界卫生组织生活质量问卷(WHOQOL-BREF)对生活质量进行了评估。结果显示,身体、心理和环境领域的生活质量均有所改善(P > 0.05),而社会领域的结果在统计学上并不显著。身体领域的得分增幅最大(10.95)。相反,社交领域的得分增幅最小(5.83)。总之,日常阿育吠陀疗法显示出了提高该群体生活质量的潜力,有助于以一种实用且经济的方式促进健康。
{"title":"Effects of Ayurvedic practices on quality of life of health professionals in Brazil: trends from a quasi experimental study","authors":"Barbara Esteves das Neves,&nbsp;Nina Claudia Barboza da Silva","doi":"10.1016/j.jaim.2024.100932","DOIUrl":"10.1016/j.jaim.2024.100932","url":null,"abstract":"<div><p>Integral health encompasses the way individuals live, considering their quality of life. An inadequate lifestyle can harm human health, increasing the risk of developing chronic non-communicable diseases, which represent 71% of the causes of death worldwide and 54.7% in Brazil. The COVID-19 pandemic has led to impacts on quality of life, resulting from lifestyle changes, especially among health professionals. This constitutes an important factor in the health-disease relationship and the core of the healthcare approach embraced by Ayurveda. The present study evaluated the role of daily Ayurvedic practices in improving the quality of life of health professionals working in the Family Health Strategy of SUS in Paty do Alferes/RJ, Brazil. Ayurveda practices based on <em>Trayopastamba</em> were introduced to 30 health professionals through lectures and guided activities from July to October 2021, spanning three months. Quality of life was assessed using the WHOQOL-BREF questionnaire before and after the intervention. An improvement in perceived quality of life was observed in the physical, psychological, and environmental domains (p &gt; 0.05), while the social domain did not show statistically significant results. The physical domain demonstrated the most substantial score increase (10.95). Conversely, the social domain displayed the smallest rise in scores (5.83). In conclusion, the daily Ayurvedic practices demonstrated the potential to enhance the quality of life in this group, contributing to health promotion in a practical and economically accessible manner.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100932"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000470/pdfft?md5=9ce32bb7cdd87c8d9de8a8dc5f5c4848&pid=1-s2.0-S0975947624000470-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141457084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1